Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ebesque XL 400mg tablets
0402010ABBFADAY
|
Ebesque XL | Quetiapine | Central Nervous System | No data available |
|
Ebesque XL 50mg tablets
0402010ABBFAAAV
|
Ebesque XL | Quetiapine | Central Nervous System | No data available |
|
Efexor 37.5mg tablets
0403040W0BBAAAA
|
Efexor | Venlafaxine | Central Nervous System | No data available |
|
Efexor 50mg tablets
0403040W0BBACAC
|
Efexor | Venlafaxine | Central Nervous System | No data available |
|
Efexor 75mg tablets
0403040W0BBABAB
|
Efexor | Venlafaxine | Central Nervous System | No data available |
|
Eldepryl 10mg/5ml syrup
0409010T0BBACAL
|
Eldepryl | Selegiline hydrochloride | Central Nervous System | No data available |
|
Elmino XL 16mg capsules
0411000F0BHABAF
|
Elmino XL | Galantamine | Central Nervous System | No data available |
|
Elmino XL 24mg capsules
0411000F0BHAAAG
|
Elmino XL | Galantamine | Central Nervous System | No data available |
|
Elmino XL 8mg capsules
0411000F0BHACAE
|
Elmino XL | Galantamine | Central Nervous System | No data available |
|
Elozar 15mg orodispersible tablets
0402010ADBEABAF
|
Elozar | Aripiprazole | Central Nervous System | No data available |
|
Eluden 4.6mg/24hours transdermal patches
0411000E0BJAAAF
|
Eluden | Rivastigmine | Central Nervous System | No data available |
|
Eluden 9.5mg/24hours transdermal patches
0411000E0BJABAG
|
Eluden | Rivastigmine | Central Nervous System | No data available |
|
Emend 125mg capsules
0406000ADBBABAB
|
Emend | Aprepitant | Central Nervous System | No data available |
|
Emend 125mg oral powder sachets
0406000ADBBADAG
|
Emend | Aprepitant | Central Nervous System | No data available |
|
Enalto 10mg orodispersible tablets
0403030X0BCABAH
|
Enalto | Escitalopram | Central Nervous System | No data available |
|
Enalto 15mg orodispersible tablets
0403030X0BCACAI
|
Enalto | Escitalopram | Central Nervous System | No data available |
|
Enalto 20mg orodispersible tablets
0403030X0BCADAJ
|
Enalto | Escitalopram | Central Nervous System | No data available |
|
Enalto 5mg orodispersible tablets
0403030X0BCAAAG
|
Enalto | Escitalopram | Central Nervous System | No data available |
|
Enodama 125mg tablets
0408010U0BCABBD
|
Enodama | Primidone | Central Nervous System | No data available |
|
Entacapone 400mg/5ml oral liquid
0409010V0AAABAB
|
Entacapone | Entacapone | Central Nervous System | No data available |
|
Epanutin 300mg capsules
0408010Q0BBAFAQ
|
Epanutin (Capsule) | Phenytoin sodium | Central Nervous System | No data available |
|
Epanutin Ready-Mixed Parenteral 250mg/5ml inj ampoules
0408020T0BBAAAA
|
Epanutin (Parenteral) | Phenytoin sodium | Central Nervous System | No data available |
|
Epidiolex 100mg/ml oral solution
0408010AMBBAAAA
|
Epidiolex | Cannabidiol | Central Nervous System | No data available |
|
Epidiolex 25mg/ml oral solution
0408010AMBBABAB
|
Epidiolex | Cannabidiol | Central Nervous System | No data available |
|
Epimaz 100mg tablets
0408010C0BCAAAB
|
Epimaz | Carbamazepine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.